← FDA DRUG APPROVALS

FDA ANDA · ANDA074339

CIMETIDINE

Sponsor: NOVITIUM PHARMA

APPLICATION
ANDA074339
TYPE
ANDA
ORIGINAL APPROVAL
1995-06-23
LATEST ACTION
2002-07-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CIMETIDINEDiscontinued
CIMETIDINE 800MG · TABLET · ORAL

Approval history

2002-07-18Manufacturing (CMC) · Supplement 5AP
2001-08-27Manufacturing (CMC) · Supplement 4AP
1996-05-14Manufacturing (CMC) · Supplement 1AP
1995-06-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →